Scarica l'app Stockscreener
129.84
1.03%
1.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$128.52
Aprire:
$127.5
Volume 24 ore:
434.88K
Relative Volume:
0.59
Capitalizzazione di mercato:
$4.44B
Reddito:
$531.29M
Utile/perdita netta:
$71.66M
Rapporto P/E:
67.14
EPS:
1.9338
Flusso di cassa netto:
$17.35M
1 W Prestazione:
-3.86%
1M Prestazione:
-9.02%
6M Prestazione:
-1.67%
1 anno Prestazione:
+82.31%
Intervallo 1D:
$127.50
$132.22
Intervallo di 1 settimana:
$127.50
$140.72
Portata 52W:
$62.07
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
129.84 | 4.39B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
Wall Street Zen Upgrades TransMedics Group (NASDAQ:TMDX) to Buy - MarketBeat
Will TransMedics Group Inc. outperform the market in YEARBuy Signal & Weekly High Potential Stock Alerts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Now An Opportune Moment To Examine TransMedics Group, Inc. (NASDAQ:TMDX)? - Yahoo Finance
How Do Investors Really Feel About TransMedics Group Inc? - Benzinga
Big Money Moves: What makes TransMedics Group Inc stock attractive todayMarket Rally & Fast Exit and Entry Trade Guides - baoquankhu1.vn
What Is TransMedics Group, Inc.'s (NASDAQ:TMDX) Share Price Doing? - 富途牛牛
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Sahm
TransMedics receives full FDA approval for heart transplant trial By Investing.com - Investing.com Nigeria
TransMedics (TMDX) Secures FDA Approval for Advanced Heart Device Trial - GuruFocus
TransMedics receives full and unconditional FDA IDE approval for next-generation OCS Heart Enhance trial - marketscreener.com
TransMedics receives full FDA approval for heart transplant trial - Investing.com
TransMedics' 650+ patient heart transplant trial gets full FDA go-ahead - Stock Titan
New York State Common Retirement Fund Sells 134,406 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out - ACCESS Newswire
Seaport Research to Host Virtual Meeting Focusing on TMDX - GuruFocus
Renaissance Group LLC Acquires Shares of 76,078 TransMedics Group, Inc. $TMDX - MarketBeat
Principal Financial Group Inc. Purchases 53,995 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TD Cowen Sticks to Its Buy Rating for TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group Names New Commercial Leader - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect - ACCESS Newswire
Commit To Buy TransMedics Group At $80, Earn 16.2% Using Options - Nasdaq
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), UnitedHealth (UNH) and Johnson & Johnson (JNJ) - The Globe and Mail
TransMedics Group Inc (NASDAQ:TMDX): A GARP Stock with Strong Growth at a Fair Price - ChartMill
Up 95% In Last 12 Months, Can TransMedics Stock Keep Climbing In 2026? - TIKR.com
TransMedics Group, Inc. (TMDX): A Bull Case Theory - Finviz
Brown Capital Management LLC Reduces Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics: Italian NOP Program Reinforces Huge International Opportunity (NASDAQ:TMDX) - Seeking Alpha
Reasons to retain TransMedics stock in your portfolio for now - MSN
TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential Amidst Robust Revenue Surge In Medical Devices - DirectorsTalk Interviews
These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More - Benzinga
TransMedics Group Inc (NASDAQ:TMDX) Shows Strong Growth Momentum and Technical Setup - ChartMill
Lisanti Capital Growth LLC Grows Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Growth with Bullish Technical Momentum - ChartMill
TransMedics Group (NASDAQ:TMDX) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
TransMedics Group Inc (TMDX) Shares Gap Down to $133.5 on Jan 30 - GuruFocus
Assessing TransMedics Group (TMDX) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Assessing TransMedics Group (TMDX) Valuation After Nasdaq 100 Inclusion - simplywall.st
Strata Critical Medical: Likely Valuation Re-Rating After Q4 Earnings (Upgrade) (SRTA) - Seeking Alpha
Is It Too Late To Consider TransMedics Group (TMDX) After Its 106% One Year Rally? - Yahoo Finance
Y Intercept Hong Kong Ltd Sells 11,812 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Even Though TransMedics Group (NASDAQ:TMDX) Has Lost US$276m Market Cap in Last 7 Days, Shareholders Are Still up 519% Over 5 Years - 富途牛牛
Universal Beteiligungs und Servicegesellschaft mbH Sells 396,232 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Precision Trading with Transmedics Group Inc. (TMDX) Risk Zones - Stock Traders Daily
Is TransMedics’ Incentive‑Backed Somerville Campus Reshaping The Investment Case For TransMedics Group (TMDX)? - Sahm
Emerald Mutual Fund Advisers Trust Sells 17,205 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
BioMed Realty and TransMedics complete 498,000 s/f lease at Assembly Innovation Park - NEREJ
Stock Analysis: What are Black Spade Acquisition II Co Equity Warrants growth leversDip Buying & Free Community Consensus Stock Picks - baoquankhu1.vn
Emerald Advisers LLC Has $43.49 Million Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX), Beam Therapeutics (BEAM) and Boston Scientific (BSX) - The Globe and Mail
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Weill David | Director |
Dec 03 '25 |
Sale |
138.64 |
5,000 |
693,200 |
12,134 |
| Hernandez Gerardo | Chief Financial Officer |
Dec 04 '25 |
Sale |
139.62 |
920 |
128,450 |
15,064 |
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):